Successful treatment of severe subcutaneous insulin resistance with inhaled insulin therapy |
| |
| Authors: | AAEM Van Alfen‐van der Velden C Noordam BE De Galan JJG Hoorweg‐Nijman PG Voorhoeve C Westerlaken |
| |
| Affiliation: | 1. Metabolic and Endocrine Diseases at the Department of Pediatrics, Radboud University Medical Centre, Nijmegen, The Netherlands;2. Canisius Wilhelmina Hospital, Nijmegen, The Netherlands;3. Department of Internal Medicine, Radboud University Medical Centre, Nijmegen, The Netherlands;4. St Antonius Hospital, Nieuwegein, The Netherlands |
| |
| Abstract: | van Alfen‐van der Velden AAEM, Noordam C, de Galan BE, Hoorweg‐Nijman JJG, Voorhoeve PG, Westerlaken C. Successful treatment of severe subcutaneous insulin resistance with inhaled insulin therapy. The potential of inhaled insulin therapy for severe resistance to subcutaneous insulin was tested in a 7‐yr old boy with type 1 diabetes mellitus. The efficiency of 1 mg inhaled insulin (Exubera®) was examined by a 4‐h euglycemic clamp study. During the clamp, the glucose infusion rate started to increase 25 min after inhalation and peaked 120 min after inhalation. Subsequently, a trial of inhaled insulin monotherapy was initiated consisting of pre‐meal inhalations and one inhalation during the night. Since glycemic control remained fair (HbA1c ～8.5%), this therapy was continued. Over the ensuing 18 months, mild keto‐acidosis occurred twice during gastro‐enteritis. Inhaled insulin was well tolerated and pulmonary function did not deteriorate. We conclude that severe resistance to subcutaneous insulin does not preclude sufficient absorption of insulin delivered by pulmonary. |
| |
| Keywords: | child diabetes mellitus type 1 inhaled insulin therapy insulin resistance |
|
|
